Dr. Constantine “Connie” Mantz joined 21st Century Oncology in 2000 and has served in his current capacity as Chief Medical Officer since February 2011 and formerly as Senior Vice President of Clinical Operations from March 2009 to February 2011. Dr. Mantz is Board Certified in Radiation Oncology by the American Board of Radiology. At 21st Century Oncology, as an area expert, he leads the company’s focus on the study and treatment of prostate and breast cancer.
Lenny Brunson leads the Information Technology team and oversees the Company's information strategy and operations. With more than 29 years of experience in information technology, Mr. Brunson joined the 21st Century Oncology team in 2016.
Kevin Glynn leads the information protection team and oversees the ongoing management of cyber security, patient privacy, HIPAA, SOX, and credit card protection in order to maintain the confidentiality, integrity, and availability of all organizational healthcare information systems and protected health information.
Betta Sherman leads the corporate and regional compliance team, implementing a program that is consistent with guidelines issued by the Office of Inspector General of the U.S. Department of Health and Human Services. Ms. Sherman has been working with 21st Century Oncology since 2015.
Gustavo Olivera is 21st Century Oncology's Chief Technical Officer. In this role, he oversees all aspects of the physics department and ensures adherence to Medical Physics quality requirements, accreditation requirements and administration, physics vendor management, and applicable state and federal laws. He is also responsible for strategic development of the physics/technology department.
Gary Delanois joined 21st Century Oncology in 2009 and serves as the Senior Vice President, United States Operations. With the goal of creating a seamless approach among multiple care specialties, Mr. Delanois facilitates health care integration to provide comprehensive care toward the best individualized treatment plan and best possible outcome for patients.
Matthew D. Anderson served as the Vice President, Chief Financial Officer and Treasurer of Pharmedium Healthcare Holdings, Inc. from January 2014 until February 2016, following the successful sale of Pharmedium to Amerisource Bergen.
Dr. Eduardo Fernandez joined 21st Century Oncology in 1998 and has served as the company's Director of Regional Operations and Senior Vice President of Physician Management in the past. In his current role, he is responsible for the oversight and support of the physician, hospital and service provider network strategy. As a Board Certified Radiation Oncologist, Dr. Fernandez also continues to be deeply involved with patient care.
Dr. Timothy D. Shafman joined 21st Century Oncology in June 2004 and has served as National Medical Director since 2014. In this role, he is involved in clinical and operational management and development for radiation therapy services throughout the company. Formerly, Dr. Shafman was the Medical Director of our Rhode Island and Massachusetts regional networks and he now sees patients in Port Charlotte, Florida.
Kimberly J. Commins-Tzoumakas has over a decade of experience as outside counsel, providing representation to health care providers, including board governance, general health law, Stark compliance, physician contracting, fraud and abuse, and corporate compliance and regulatory issues.
Jill Kreissl joined 21st Century Oncology in the spring of 2016, to create and implement a human resources strategic plan aligned with the company’s goals for growth through acquisition and expansion. She provides oversight of the development of talent management, policy development, and the development of patient and employee-focused corporate culture initiatives.